Evidence map›Paper›PMID 28465248›Full record

ReviewProgress in retinal and eye research2017

Roles of exosomes in the normal and diseased eye.

Mikael Klingeborn, W Michael Dismuke, Catherine Bowes Rickman, W Daniel Stamer

Registry-linked trialAbstract readReview
In one paragraph

Review in Progress in retinal and eye research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05413148 (The Effect of Wharton Jelly-derived Mesenchymal Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa), which is not on this map. Cited by 108 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05413148 phase2 / phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

The Effect of Wharton Jelly-derived Mesenchymal Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa

TypeinterventionalSponsorTC Erciyes UniversityRan2022 to 2023Enrolled135ConditionsRetinitis PigmentosaArmsSubtenon injection of Wharton jelly derived mesenchymal stem cells, Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes, Placebo
3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Monocyte-derived exosomal periostin driven by histone lactylation contributes to retinal neovascularization.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. The RNA content of extracellular vesicles from gene-editedMolecular therapy. Methods & clinical development · 2025
    Article
  18. Article
  19. PARP inhibition preserves cone photoreceptors in rd2 retina.Acta neuropathologica communications · 2025
    Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mikael KlingebornDepartment of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710, USA.
W Michael DismukeDepartment of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710, USA.
Catherine Bowes RickmanDepartment of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710, USA; Department of Cell Biology, Duke University, Durham, NC 27710, USA.
W Daniel StamerDepartment of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710, USA; Department of Biomedical Engineering, Duke University, Durham, NC 27710, USA. Electronic address: dan.stamer@duke.edu.

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Goldis Malek · 1985 to 2026
$19.3M
The Mechanical Basis of Primary Open Angle GlaucomaR01EY019696 · NEI · NORTHWESTERN UNIVERSITY · PI FREDBERG, JEFFREY J, JOHNSON, MARK · 2009 to 2019
$7.6M
eNOS-Dependent Mechanoregulation of Intraocular PressureR01EY022359 · NEI · DUKE UNIVERSITY · PI STAMER, W DANIEL · 2012 to 2025
$5.6M
Innate immunity, lipoproteins and AMD progressionR01EY026161 · NEI · DUKE UNIVERSITY · PI BOWES RICKMAN, CATHERINE · 2016 to 2019
$2.0M
MicroRNA-directed modulation of intraocular pressureR01EY023287 · NEI · DUKE UNIVERSITY · PI GONZALEZ, PEDRO, STAMER, W DANIEL · 2013 to 2016
$1.6M
Shear stress regulation of barrier function in Schlemm's canalF32EY023468 · NEI · DUKE UNIVERSITY · PI DISMUKE, WILLIAM MICHAEL · 2014 to 2015
$117k
NEI NIH HHS F32 EY023468NEI NIH HHS P30 EY005722NEI NIH HHS R01 EY019696NEI NIH HHS R01 EY022359NEI NIH HHS R01 EY023287NEI NIH HHS R01 EY026161
6 · The paper itself

Abstract

Exosomes are nanometer-sized vesicles that are released by cells in a controlled fashion and mediate a plethora of extra- and intercellular activities. Some key functions of exosomes include cell-cell communication, immune modulation, extracellular matrix turnover, stem cell division/differentiation, neovascularization and cellular waste removal. While much is known about their role in cancer, exosome function in the many specialized tissues of the eye is just beginning to undergo rigorous study. Here we review current knowledge of exosome function in the visual system in the context of larger bodies of data from other fields, in both health and disease. Additionally, we discuss recent advances in the exosome field including use of exosomes as a therapeutic vehicle, exosomes as a source of biomarkers for disease, plus current standards for isolation and validation of exosome populations. Finally, we use this foundational information about exosomes in the eye as a platform to identify areas of opportunity for future research studies.

Indexed as

Cell CommunicationCell DifferentiationExosomesHumansRetinaWet Macular DegenerationAge-related macular degenerationBiomarkerExosomeExtracellular vesicleGlaucomaProteome

Identifiers

PMID28465248
PMCPMC5537591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.